Company intelligence / Profile preview

Jace Biomedical, Inc.

Salem, Wisconsin, United Statesjacebio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has not yet entered clinical trials. Current efforts are focused on compound optimization and preclinical development with plans to move into clinical trials targeting Alzheimer’s disease and related disorders caused by protein aggregation[4].

Therapeutic areas: Rare DiseasesNeurology
Modalities: Small molecules (focus on therapies for proteotoxic diseases)
Industry: Biotech

Partnerships

Collaboration with Dr. Luigi Puglielli, University of Wisconsin-Madison for foundational technology/research translation[4].

Beyond the preview

Go deeper on Jace Biomedical, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jace Biomedical, Inc..

Explore the full profile